A Study to Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV)

Condition:   Hepatitis CInterventions:   Drug: Telaprevir;   Drug: Ribavirin;   Biological: Pegylated Interferon Alfa-2a;   Drug: Highly Active Antiretroviral Therapy (HAART)Sponsor:   Vertex Pharmaceuticals IncorporatedTerminated - verified March 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials